Davide Prosperi is Full Professor of Biochemistry at the University of Milano-Bicocca and Director of the University Nanomedicine Center (NanoMib). He has over 25 years of experience in nanomedicine and bio-nanotechnology, with a research focus on engineered nanoparticles, targeted drug delivery, RNA nanomedicine, molecular imaging and cancer immunotherapy. His group develops innovative nanoplatforms for precision oncology, including biomimetic lipid nanoparticles, protein nanocages and multifunctional systems designed to overcome biological barriers, target the tumor microenvironment and counteract therapeutic resistance. He has authored 180 publications, holds an H-index of 42 (Scopus), and has coordinated over €10 million in competitive research funding as principal investigator.
CRDWC 2026
Oral Presentation